Cargando…

Relationship between the expression of oestrogen receptor and progesterone receptor and (18)F-FDG uptake in endometrial cancer

Background: Progestogens have been widely used for the treatment of inoperable endometrial cancer or younger patients with endometrial cancer. Identifying markers that are predictive of a response to progestogens is critical for successful therapy. Molecular imaging with (18)F(-)fluorodeoxyglucose p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chunhua, Chen, Ruohua, Xu, Lian, Chen, Yumei, Wang, Yining, Huang, Gan, Liu, Jianjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377875/ https://www.ncbi.nlm.nih.gov/pubmed/32639950 http://dx.doi.org/10.18632/aging.103352

Ejemplares similares

Relationship between PD-L1 expression and (18)F-FDG uptake in gastric cancer
por: Chen, Ruohua, et al.
Publicado: (2019)

Delayed (18)F-FDG PET/CT Appearance of Urachal Adenocarcinomas
por: Xu, Lian, et al.
Publicado: (2020)

Preoperative evaluation of residual tumor in patients with endometrial carcinoma by using (18)F-FDG PET/CT
por: Wu, Chunhua, et al.
Publicado: (2020)

Preoperative PET/CT (18)F-FDG Standardized Uptake by Lymph Nodes as a Significant Prognostic Factor in Patients with Colorectal Cancer
por: Chen, Ruohua, et al.
Publicado: (2018)

Delayed post-diuretic (18)F-FDG PET/CT for preoperative evaluation of renal pelvic cancer
por: Shi, Yiping, et al.
Publicado: (2020)

Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas
por: Reich, O, et al.
Publicado: (2000)

The Role of (18)F-FDG PET/CT in the Evaluation of Peritoneal Thickening of Undetermined Origin
por: Chen, Ruohua, et al.
Publicado: (2016)

Use of (68)Ga-PSMA-11 and (18)F-FDG PET-CT Dual-Tracer to Differentiate Between Lymph Node Metastases and Ganglia
por: Shi, Yiping, et al.
Publicado: (2021)

The Heterogeneous Metabolic Patterns of Ganglia in (68)Ga-PSMA, (11)C-choline, and (18)F-FDG PET/CT in Prostate Cancer Patients
por: Shi, Yiping, et al.
Publicado: (2021)

Fructose 1,6-Bisphosphatase 1 Expression Reduces (18)F-FDG Uptake in Clear Cell Renal Cell Carcinoma
por: Chen, Ruohua, et al.
Publicado: (2019)

The role of oestrogen and progesterone receptors in gigantomastia
por: Kasielska-Trojan, Anna, et al.
Publicado: (2019)

Oestrogen and progesterone receptor distribution in the cancerous breast.
por: Panahy, C., et al.
Publicado: (1987)

The role of oestrogen and progesterone receptors in breast cancer – immunohistochemical evaluation of oestrogen and progesterone receptor expression in invasive breast cancer in women
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2015)

Evaluation of Expression of the PTEN Gene, Oestrogen and Progesterone Receptors as Diagnostic and Predictive Factors in Endometrial Cancer
por: Samulak, Dariusz, et al.
Publicado: (2013)

Intrathoracic myolipoma from parietal pleura with oestrogen and progesterone receptor
por: Teh, Jyh Shinn, et al.
Publicado: (2021)

Oestrogen increases S-phase fraction and oestrogen and progesterone receptors in human cervical cancer in vivo.
por: Bhattacharya, D., et al.
Publicado: (1997)

A predicting model of bone marrow malignant infiltration in (18)F-FDG PET/CT images with increased diffuse bone marrow FDG uptake
por: Zhou, Mingge, et al.
Publicado: (2018)

Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
por: Lee, Shi Hao, et al.
Publicado: (2022)

Alcohol consumption and breast cancer oestrogen and progesterone receptor status
por: Enger, S M, et al.
Publicado: (1999)

Progesterone Receptor–Mediated Regulation of Cellular Glucose and (18)F-Fluorodeoxyglucose Uptake in Breast Cancer
por: Salem, Kelley, et al.
Publicado: (2022)

Prognostic Values of TIGAR Expression and (18)F-FDG PET/CT in Clear Cell Renal Cell Carcinoma
por: Wang, Xiaoyan, et al.
Publicado: (2020)

Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status
por: McCredie, M R E, et al.
Publicado: (2003)

Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples.
por: Baker, V. A., et al.
Publicado: (1992)

Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours.
por: Pichon, M. F., et al.
Publicado: (1992)

The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer
por: Davey, M G, et al.
Publicado: (2021)

Oestrogen and progesterone cytosolic receptors in clinically inflammatory tumours of the human breast.
por: Delarue, J. C., et al.
Publicado: (1981)

The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.
por: Howat, J. M., et al.
Publicado: (1985)

Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
por: Alanko, A., et al.
Publicado: (1984)

Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
por: Lee, Shi Hao, et al.
Publicado: (2023)

The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer
por: Xu, Wei, et al.
Publicado: (2020)

Progesterone receptors – animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis
por: Anderson, Elizabeth
Publicado: (2002)

Is oestrogen receptor-negative/progesterone receptor-positive (ER−/PR+) a real pathological entity?
por: Onitilo, Adedayo A, et al.
Publicado: (2021)

Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study
por: Karat, D, et al.
Publicado: (1999)

The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer : Erratum
por: Xu, Wei, et al.
Publicado: (2021)

Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer
por: Wang, Caifeng, et al.
Publicado: (2020)

Intra-tumoural variation of oestrogen receptor status in endometrial cancer.
por: Castagnetta, L., et al.
Publicado: (1983)

Oestrogen receptor pathway activity is associated with outcome in endometrial cancer
por: van Weelden, Willem Jan, et al.
Publicado: (2020)

Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer
por: Kavlashvili, Tamar, et al.
Publicado: (2016)

MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer
por: Lowery, Aoife J, et al.
Publicado: (2009)

Head-to-Head Comparison between (18)F-FES PET/CT and (18)F-FDG PET/CT in Oestrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-Analysis
por: Piccardo, Arnoldo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7j86hai87ogk1k4jfu2pq1e1th